Smartphone-Guided Perioperative Rehabilitation vs Standard Care in Gastric Cancer: RCT Targets 90-Day Complication Rates After Neoadjuvant Therapy

References

1. 1.Beijing Friendship Hospital. (2025). The effect of perioperative rehabilitation programme delivered via a smart phone based digital platform in patients undergoing neoadjuvant therapy for gastric cancer surgery: Study protocol for a randomised controlled trial (NCT07441850). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07441850
2. 2.Waterland, J. L., McCourt, O., Edbrooke, L., Granger, C. L., Ismail, H., Riedel, B., & Denehy, L. (2021). Efficacy of prehabilitation including exercise on postoperative outcomes following abdominal cancer surgery: A systematic review and meta-analysis. Frontiers in Surgery, 8, 628848. https://doi.org/10.3389/fsurg.2021.628848
3. 3.Li, C., Carli, F., Lee, L., Charlebois, P., Stein, B., Liberman, A. S., Kaneva, P., Augustin, B., Wongyingsinn, M., Gamsa, A., Kim, D. J., Vassiliou, M. C., & Feldman, L. S. (2013). Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: A pilot study. Surgical Endoscopy, 27(4), 1072–1082. https://doi.org/10.1007/s00464-012-2560-5
4. 4.Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
5. 5.Al-Batran, S. E., Homann, N., Pauligk, C., Goetze, T. O., Meiler, J., Kasper, S., Kopp, H. G., Mayer, F., Haag, G. M., Luley, K., Lindig, U., Schmiegel, W., Pohl, M., Stoehlmacher, J., Folprecht, G., Probst, S., Prasnikar, N., Fischbach, W., Mahlberg, R., … Illerhaus, G. (2019). Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): A randomised, phase 2/3 trial. The Lancet, 393(10184), 1948–1957. https://doi.org/10.1016/S0140-6736(18)32557-1
6. 6.Mazzola, R., Jereczek-Fossa, B. A., Livi, L., Alongi, F., & Greto, D. (2022). Digital health in oncology: Opportunities and challenges for patient-centred care. Frontiers in Oncology, 12, 893390. https://doi.org/10.3389/fonc.2022.893390